Teyssedou Lenaic Nathanaelinsider trades
In SEC Form 4 filings, Teyssedou Lenaic Nathanael is listed as PRINCIPAL ACCOUNTING OFFICER of Addex Therapeutics Ltd. (ADXN). Teyssedou Lenaic Nathanael reported no open-market purchases or sales in the last 90 days. The latest Form 4 transaction on record was filed on Sep 4.
Companies and roles
| Company | Role | Transactions | Last filed |
|---|---|---|---|
| ADXNAddex Therapeutics Ltd. | PRINCIPAL ACCOUNTING OFFICER | 16 | Sep 4 |
Cluster buys
No cluster buy in the last 90 days included a purchase by this insider (two or more insiders buying within 14 days).
Form 4 historysince 2026-09-04
| Company | Traded | Filed | Type | Shares | Price | Value | Owned after | 10b5-1 plan | Filing |
|---|---|---|---|---|---|---|---|---|---|
| ADXNAddex Therapeutics Ltd. | Sep 2 | Sep 4 | D · derivative | 37,770 | $0.16 | $6,043 | 565,138 | No | Form 4 |
| ADXNAddex Therapeutics Ltd. | Sep 2 | Sep 4 | A · derivative | 37,770 | $0.03 | $1,209 | 602,908 | No | Form 4 |
| ADXNAddex Therapeutics Ltd. | Sep 2 | Sep 4 | D · derivative | 59,530 | $0.16 | $9,525 | 543,378 | No | Form 4 |
| ADXNAddex Therapeutics Ltd. | Sep 2 | Sep 4 | A · derivative | 59,530 | $0.03 | $1,905 | 602,908 | No | Form 4 |
| ADXNAddex Therapeutics Ltd. | Sep 2 | Sep 4 | D · derivative | 10,000 | $0.16 | $1,600 | 592,908 | No | Form 4 |
| ADXNAddex Therapeutics Ltd. | Sep 2 | Sep 4 | A · derivative | 10,000 | $0.03 | $320 | 602,908 | No | Form 4 |
| ADXNAddex Therapeutics Ltd. | Sep 2 | Sep 4 | D · derivative | 30,000 | $0.16 | $4,800 | 572,908 | No | Form 4 |
| ADXNAddex Therapeutics Ltd. | Sep 2 | Sep 4 | A · derivative | 30,000 | $0.03 | $960 | 602,908 | No | Form 4 |
| ADXNAddex Therapeutics Ltd. | Sep 2 | Sep 4 | D · derivative | 65,620 | $0.16 | $10,499 | 537,288 | No | Form 4 |
| ADXNAddex Therapeutics Ltd. | Sep 2 | Sep 4 | A · derivative | 65,620 | $0.03 | $2,100 | 602,908 | No | Form 4 |
| ADXNAddex Therapeutics Ltd. | Sep 2 | Sep 4 | D · derivative | 90,529 | $0.16 | $14,485 | 512,379 | No | Form 4 |
| ADXNAddex Therapeutics Ltd. | Sep 2 | Sep 4 | A · derivative | 90,529 | $0.03 | $2,897 | 602,908 | No | Form 4 |
| ADXNAddex Therapeutics Ltd. | Sep 2 | Sep 4 | D · derivative | 208,974 | $0.05 | $11,076 | 393,934 | No | Form 4 |
| ADXNAddex Therapeutics Ltd. | Sep 2 | Sep 4 | A · derivative | 208,974 | $0.03 | $6,687 | 602,908 | No | Form 4 |
| ADXNAddex Therapeutics Ltd. | Sep 2 | Sep 4 | D · derivative | 100,485 | $0.06 | $6,230 | 502,423 | No | Form 4 |
| ADXNAddex Therapeutics Ltd. | Sep 2 | Sep 4 | A · derivative | 100,485 | $0.03 | $3,216 | 602,908 | No | Form 4 |
Published from this insider's public Form 4 filings on SEC EDGAR; the name is shown as filed. Named in a filing and want this page removed? See the privacy policy.